Home/Filings/4/0000899243-18-010750
4//SEC Filing

PETERS KEVIN G. 4

Accession 0000899243-18-010750

CIK 0001422142other

Filed

Apr 24, 8:00 PM ET

Accepted

Apr 25, 8:26 PM ET

Size

5.5 KB

Accession

0000899243-18-010750

Insider Transaction Report

Form 4
Period: 2018-04-23
PETERS KEVIN G.
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-04-23+100,000100,000 total
    Exercise: $3.59Exp: 2028-04-23Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]Options exercisable as to 1/4th on the first anniversary of the grant date and an additional 1/48th monthly thereafter until the fourth anniversary of the grant date.

Issuer

Aerpio Pharmaceuticals, Inc.

CIK 0001422142

Entity typeother

Related Parties

1
  • filerCIK 0001700663

Filing Metadata

Form type
4
Filed
Apr 24, 8:00 PM ET
Accepted
Apr 25, 8:26 PM ET
Size
5.5 KB